Archive for February, 2010
Art students who cannot draw: Exploring the relations between drawing ability, visual memory, accuracy of copying, and dyslexia.
Some art students, despite being at art school, cannot draw very well, and would like to be able to draw well. It has been suggested that poor drawing may be a particular problem for students with dyslexia (and a high proportion of art school students is dyslexic). In Study 1 we studied 277 art students, using a questionnaire to assess self-perceived drawing ability and a range of background measures, including demography, education, a history of dyslexia, a self-administered spelling test, and personality and educational variables. In Study 2 we gave detailed drawing tests to a sample of 38 of the art students, stratified by self-rated drawing ability and spelling ability, and to 30 control participants. Students perceiving themselves as g…
No commentsArk Therapeutics Files Cerepro(R) Re-Examination Documentation With The European Medicines Agency
Ark Therapeutics Group plc (AKT: LSE) (”Ark” or “the Company”), announces that it has filed documentation with the European Medicines Agency (”EMA”) in relation to its request for re-examination of the marketing approval application (”MAA”) for Cerepro®, Ark’s novel gene based therapy for the treatment of operable malignant glioma (brain cancer)…Original post by Allergy News From Medical News Today
No commentsNHS Could Save Millions By Investing In Specialist Nurses, England
Meg Macarthur, Senior Policy Officer at Breakthrough Breast Cancer says: “The threat to breast care and other specialist nurses is potentially devastating to patients. We know that these nurses play a significant role in their care and recovery, offering an invaluable service throughout their treatment journey…Original post by Allergy News From Medical News Today
No commentsGenta Initiates Once-Weekly Treatment Schedule For Tesetaxel, A Novel Oral Tubulin Inhibitor, In New Dose-Ranging Study
Genta Incorporated (OTCBB: GETA) announced that the Company has initiated a new dose-ranging study of tesetaxel, the Company’s novel oral tubulin inhibitor, using a weekly dosing regimen. Tesetaxel — a late Phase 2 oncology product — is the leading oral taxane currently in clinical development…Original post by Allergy News From Medical News Today
No commentsCells Of Aggressive Leukemia Hijack Normal Protein To Grow
Researchers have found that one particularly aggressive type of blood cancer, mixed lineage leukemia (MLL), has an unusual way to keep the molecular motors running. The cancer cells rely on the normal version of an associated protein to stay alive. MLL happens when a piece of chromosome 11 breaks off at the normal MLL-associated gene…Original post by Allergy News From Medical News Today
No commentsJefferson Surgeon Receives Outstanding Performance Award From American College Of Surgeons Commission On Cancer
Adam Berger, M.D., a Cancer Liaison Physician (CLP) at Thomas Jefferson University Hospital, recently received an Outstanding Performance Award for going above and beyond the scope of the normal duties of serving as a liaison between the hospital’s cancer program and the American College of Surgeons Commission on Cancer (CoC)…Original post by Allergy News From Medical News Today
No commentsOral Immunotherapy Has Potential For Treating Egg Allergic Children
Could a treatment for egg allergy be on the horizon? Late-breaking research presented at the 2010 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) shows promising results for parents of egg allergic children…Original post by Allergy News From Medical News Today
No commentsCan Folate And Food Allergen Intake During Pregnancy Put Your Child At Risk For Allergies Or Asthma?
It has long been known that the choices you make during pregnancy can have a lasting impact, but new research shows that certain behaviors could influence whether your child will develop food allergies or asthma…Original post by Allergy News From Medical News Today
No commentsIs Anaphylaxis Triggered By Eating Meat More Common Than We Think?
According to research presented at the 2010 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), a carbohydrate in meat called alpha-gal is an under recognized culprit in patients with recurring anaphylaxis…Original post by Allergy News From Medical News Today
No commentsVCU Massey Cancer Center Receives NIH Grant
The National Institutes of Health has awarded the Virginia Commonwealth Massey Cancer Center a National Cancer Institute grant totaling nearly $3 million to develop a standardized test to measure health literacy among cancer patients. The four-year grant will be led by Levent Dumenci, Ph.D…Original post by Allergy News From Medical News Today
No comments